Organization - Additional Information (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Jul. 07, 2025 |
Mar. 13, 2025 |
Jan. 28, 2025 |
Jun. 30, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
| Organization [Line Items] | |||||||
| Restructuring charge | $ 0 | ||||||
| Restructuring related liability | 0 | ||||||
| Accumulated deficit | $ (447,083,000) | $ (447,083,000) | $ (312,648,000) | ||||
| Cash and cash equivalents and marketable securities | $ 252,600,000 | 252,600,000 | |||||
| Cash flows from operations | $ (115,077,000) | $ (65,230,000) | |||||
| Workforce reduction percentage | 50.00% | ||||||
| Concentra Biosciences, LLC | |||||||
| Organization [Line Items] | |||||||
| Merger agreement, date | Jul. 07, 2025 | ||||||
| Cash tender offer price per share of common stock | $ 4.379 | $ 4.379 | |||||
| 2025 Restructuring | |||||||
| Organization [Line Items] | |||||||
| Restructuring charge | $ 37,100,000 | $ 83,400,000 | |||||
| Workforce reduction percentage | 90.00% | ||||||
| X | ||||||||||
- Definition Cash and cash equivalents and marketable securities. No definition available.
|
| X | ||||||||||
- Definition Organization. No definition available.
|
| X | ||||||||||
- Definition Date when acquisition agreement is executed in business combination, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). No definition available.
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|